While we are all aware of the use of genomics in cancer susceptibility, such as BRCA, there is now new evidence supporting the clinical analysis of multiple genes to calculate a polygenic risk score for many common diseases. Dr. Evans will explain the role of this new genetic technology in longevity and precision-driven clinical practice, where clinicians are given actual short term and lifetime risks of many common illnesses, such as breast cancer, ovarian cancer, Type II Diabetes and heart disease. This valuable information allows for informed decision-making when considering enhanced disease screening and risk-reduction strategies. Providers can now offer their patients the latest in disease risk prediction in order to create personalized treatment plans to increase health span, wellness and longevity.
Learning Objectives:
- Explain the basics of predictive genomics.
- Explain how predictive genomics impacts longevity medicine.
- Explain the actionable interventions to alter predictive genomics outcomes.
